Jul 31, 2017 12:30 pm UTC| Business
CHARLOTTESVILLE, Va., July 31, 2017 -- Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN), a clinical stage biotechnology company developing novel small molecule therapeutics for cancer and other hypoxia-related diseases,...
ABLE NATIONAL RESOURCE CENTER LAUNCHES #ABLETOSAVE CAMPAIGN
Jul 31, 2017 12:30 pm UTC| Business
Washington, D.C., July 31, 2017 -- ABLE National Resource Center announced today the launch of #ABLEtoSave, a month-long grassroots education and informational campaign about Achieving a Better Life Experience (ABLE)...
Jul 31, 2017 12:30 pm UTC| Business
EDINBURG, Va., July 31, 2017 -- Shenandoah Telecommunications Company (“Shentel”) (NASDAQ:SHEN) today announced that Adele Skolits, Chief Financial Officer, will present at Oppenheimer’s 20th Annual Technology, Internet...
Genco Shipping & Trading Limited Announces Second Quarter 2017 Conference Call and Webcast
Jul 31, 2017 12:30 pm UTC| Business
NEW YORK, July 31, 2017 -- Genco Shipping Trading Limited (NYSE:GNK) announced today that it will hold a conference call to discuss the Company’s results for the second quarter of 2017 on Tuesday, August 8, 2017 at...
Fulgent Genetics to Announce Second Quarter 2017 Financial Results on August 7, 2017
Jul 31, 2017 12:30 pm UTC| Business
TEMPLE CITY, Calif., July 31, 2017 -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2017 financial results after the market closes on...
HomeTrust Bank to Open Commercial Loan Production Office in Greensboro, N.C.
Jul 31, 2017 12:30 pm UTC| Business
ASHEVILLE, N.C., July 31, 2017 -- HomeTrust Bancshares, Inc. (the “Company”) (NASDAQ:HTBI), the holding company for HomeTrust Bank (“Bank”), has announced plans to open a Commercial Loan Production Office (“LPO”) in...
SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs
Jul 31, 2017 12:30 pm UTC| Business
SAN RAMON, Calif., July 31, 2017 -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral...